{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:35:37Z","timestamp":1761489337812,"version":"3.40.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.vaccine.2014.03.023","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T05:42:09Z","timestamp":1395466929000},"page":"2618-2622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Phase I clinical trial of O-acetylated pectin conjugate, a plant polysaccharide based typhoid vaccine"],"prefix":"10.1016","volume":"32","author":[{"given":"Shousun C.","family":"Szu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimi F.-Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2884-9201","authenticated-orcid":false,"given":"Chiayung","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Duc","family":"Thinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.03.023_bib0005","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0010","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2471\/BLT.06.039818","article-title":"A study of typhoid fever in five Asian countries: disease burden and implications for control","volume":"86","author":"Ochai","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/AAC.00447-06","article-title":"Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin\u2013azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever","volume":"51","author":"Parry","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0020","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4269\/ajtmh.2007.76.706","article-title":"Geographical distribution and risk factors associated with enteric diseases in Vietnam","volume":"76","author":"Kelly-Hope","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0025","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0140-6736(98)09001-1","article-title":"Typhoid fever in children ages less than 5 years","volume":"354","author":"Sinha","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0030","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3201\/eid1102.040422","article-title":"Bacteremic typhoid fever in children in an urban slum, Bangladesh","volume":"11","author":"Brooks","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0035","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(87)91316-X","article-title":"Protective activity of Vi capsular polysaccharide vaccine against typhoid fever","volume":"ii","author":"Klugman","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0040","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1001\/archinte.1995.00430210041007","article-title":"A new typhoid vaccine composed of the Vi capsular polysaccharide","volume":"155","author":"Plotkin","year":"1995","journal-title":"Arch Int Med"},{"article-title":"Requirements for Vi polysaccharide for typhoid. (Requirements for Biological Substances No. 48)","year":"1994","series-title":"WHO Expert Committee on Biologic Standardization; Forty Third Report","key":"10.1016\/j.vaccine.2014.03.023_bib0045"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0050","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1016\/j.vaccine.2012.06.015","article-title":"Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan","volume":"30","author":"Khan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.vaccine.2007.11.007","article-title":"Revaccination does not improve an observed deficit in antibody responses in Pakistani adults born of a lower birth weight","volume":"26","author":"Moore","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0060","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/IAI.67.11.5806-5810.1999","article-title":"Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"67","author":"Kossaczka","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0065","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM200310023491423","article-title":"Persistent efficacy of Vi conjugates against typhoid fever in young children","volume":"349","author":"Lanh","year":"2003","journal-title":"N Eng J Med"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0070","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CVI.00532-10","article-title":"The Vi conjugate typhoid vaccine is safe, elicites protective levels of IgG anti-Vi, and is compatible with routine infant vaccines","volume":"18","author":"Thiem","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0075","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1586\/14760584.2013.845529","article-title":"Development of Vi conjugate\u2013a new generation of typhoid vaccine","volume":"12","author":"Szu","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0080","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0076-6879(03)01079-6","article-title":"Physical, chemical, antigenic, and immunologic characterization of polygalacturonan, its derivatives, and Vi antigen from Salmonella Typhi","volume":"363","author":"Szu","year":"2003","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0301-4622(94)00002-6","article-title":"O-acetylation affects the binding properties of the carboxyl groups on the Vi bacterial polysaccharide","volume":"51","author":"Bystricky","year":"1994","journal-title":"Biophys Chem"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0090","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/JCM.26.4.719-725.1988","article-title":"Application of optical properties of the Vi capsular polysaccharide for quantitation of the Vi antigen in vaccines for typhoid fever","volume":"26","author":"Stone","year":"1988","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0095","first-page":"53","article-title":"Pectic substances and other uronides","volume":"vol. 1","author":"Pilnik","year":"1970"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0100","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1128\/IAI.62.12.5545-5549.1994","article-title":"Synthesis and some immunologic properties of an O-acetyl pectin [poly(1\u21924)-alpha-D-GalpA]-protein conjugate as a vaccine for typhoid fever","volume":"62","author":"Szu","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0105","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.65.6.2088-2093.1997","article-title":"Synthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linker","volume":"65","author":"Kossaczka","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0021-9258(18)56740-5","article-title":"The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application","volume":"180","author":"Hestrin","year":"1949","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0115","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1128\/IAI.62.10.4440-4444.1994","article-title":"Laboratory and preliminary clinical characterization of Vi capsular polysaccharide\u2013protein conjugate vaccines","volume":"62","author":"Szu","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0120","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1073\/pnas.87.1.308","article-title":"Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity","volume":"87","author":"Chaudhary","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0125","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0003-2697(62)90095-7","article-title":"A modified uronic acid carbazole reaction","volume":"4","author":"Bitter","year":"1962","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0003-2697(92)90194-C","article-title":"A colorimetric method for the quantitation of uronic acids and a specific assay for galacturonic acid","volume":"201","author":"Taylor","year":"1992","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0135","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.vaccine.2013.02.006","article-title":"A human IgG anti-Vi reference for Salmonella enteric serovar Typhi with weight-based antibody units assigned","volume":"31","author":"Szu","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2014.02.050","article-title":"Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever \u2013 based on the efficacy trial of Vi conjugate in young children","author":"Szu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0145","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1128\/IAI.68.3.1529-1534.2000","article-title":"Phase 1 and phase 2 studies of Salmonella enteric serovar Paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"68","author":"Konadu","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0150","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.vaccine.2004.11.019","article-title":"Plant-derived vaccines against diarrheal diseases","volume":"23","author":"Tacket","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0155","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.vaccine.2012.10.094","article-title":"Developing plant-based vaccines against neglected tropical diseases: where are we","volume":"31","author":"Rosales-Mendoza","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0160","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3109\/08820131003622643","article-title":"Transgenic plant-based oral vaccines","volume":"39","author":"Lugade","year":"2010","journal-title":"Immunol Invest"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0165","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.vaccine.2005.01.090","article-title":"Plant-derived vaccines and antibodies: potential and limitations","volume":"23","author":"Arntzen","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0170","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10719-012-9451-9","article-title":"Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component","volume":"30","author":"Wetter","year":"2013","journal-title":"Glycoconj J"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0175","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/CVI.00144-06","article-title":"Phase I clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b in human adult volunteers","volume":"13","author":"Tora\u00f1o","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.03.023_bib0180","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1073\/pnas.96.9.5194","article-title":"Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1","volume":"96","author":"Pozsgay","year":"1999","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14003673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14003673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T20:14:44Z","timestamp":1648671284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14003673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":36,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0264410X14003673"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase I clinical trial of O-acetylated pectin conjugate, a plant polysaccharide based typhoid vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}